Brain structures and neurotransmitters regulating aggression in cats: Implications for human aggression

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 25, Issue 1, 2001, Pages 91-140

  Gregg, Thomas R ^a   Siegel, Allan ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Aggression; Cat; GABA; Hypothalamus; Neuropeptides; Neurotransmitters; Periaqueduct al gray; Substance P

Indexed keywords

4 AMINOBUTYRIC ACID; CHOLECYSTOKININ; DOPAMINE; GLUTAMIC ACID; NEUROKININ; NEUROTRANSMITTER; NORADRENALIN; OPIATE PEPTIDE; SUBSTANCE P;

AGGRESSION; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN DEPTH STIMULATION; BRAIN REGION; CAT; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; GABAERGIC SYSTEM; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; LIMBIC SYSTEM; NEUROANATOMY; NEUROTRANSMISSION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PREDATION; REVIEW;

EID: 0035109959     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(00)00150-0     Document Type: Article

References (205)

1. Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease
2. Constitutive G(i2)-dependent activation of adenylyl cyclase type II by the 5-HT1A receptor. Inhibition by anxiolytic partial agonists
3. Personality and emotional disorders associated with hypothalamic lesions
4. Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers
5. Differentiation by morphine of two types of aggressive behavior in the convict cichlid (Cichlasoma nigrofasciatum)
6. Amygdala input to medial prefrontal cortex (mPFC) in the rat: A light and electron microscope study
7. Tissue concentrations of clozapine and its metabolites in the rat
8. Identification of hypothalamic and midbrain periaqueductal grey neurones mediating aggressive and defensive behaviour by intracerebral microinjections of excitatory amino acids
9. Some forebrain mechanisms involved in expression of rage with special reference to suppression of angry behavior
10. Intrahypothalamic injections of norepinephrine facilitate feline affective aggression via alpha-2 adrenoceptors
11. The effects of intrahypothalamic injections of norepinephrine upon affective defense behavior in the cat
12. Elicitation of emotional behavior by electrical or chemical stimulation applied at the same loci in cat mesencephalon
13. The effect of selected drugs on the "emotional" behavior elicited via hypothalamic stimulation
14. Temporal lobe epilepsy - A syndrome of sensory-limbic hyperconnection
15. An excitatory amino acid projection from ventromedial hypothalamus to periaqueductal gray in the rat: Autoradiographic and electrophysiological evidence
16. Excitatory amino acid projections to the periaqueductal gray in the rat: A retrograde transport study utilizing d[3H]aspartate and [3H]GABA
17. Possible origin of glutamatergic projections to the midbrain periaqueductal gray and deep layer of the superior colliculus of the rat
18. Morphine and human aggression
19. Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats
20. c-Fos expression as a tool to search for the neurobiological base of the sexual behaviour of males
21. Effects of electrical stimulation of the amygdala upon trigeminal sensory fields established during hypothalamically-elicited quiet biting attack in the cat
22. Carbachol-induced agonistic behavior in cats: Aggressive or defensive response?
23. Regional specificity of the emotional-aversive response induced by carbachol in the cat brain: A quantitative mapping study
24. Effects of experimental temporal lobe seizures upon hypothalamically elicited aggressive behavior in the cat
25. An analysis of the mechanisms underlying septal area control of hypothalamically elicited aggression in the cat
26. Effects of the opiate antagonist naloxone upon hypothalamically elicited affective defense behavior in the cat
27. Effects of D-Ala2-Met5-enkephalinamide microinjections placed into the bed nucleus of the stria terminalis upon affective defense behavior in the cat
28. Microinjection of D-ala2-met5-enkephalinamide placed into the nucleus accumbens suppresses feline affective defense behavior
29. The role of typical and atypical antipsychotic medications in the management of agitation and aggression
30. Open-label treatment with risperidone of 26 psychiatrically-hospitalized children and adolescents with mixed diagnoses and aggressive behavior
31. The aggression questionnaire
32. The intrinsic organization of the central extended amygdala
33. Effects of d-amphetamine on human aggressive responding maintained by avoidance of provocation
34. GABA receptor mediated suppression of defensive rage behavior elicited from the medial hypothalamus of the cat: Role of the lateral hypothalamus
35. Neuroanatomic projections related to biting attack elicited from ventral midbrain in cats
36. Neural pathways associated with hypothalamically elicited attack behavior in cats
37. The mouse 5-HT2B receptor: Possible involvement in trophic functions of serotonin
38. Monosynaptic pathway from cardiovascular neurons in the nucleus tractus solitarii to the paraventricular nucleus in the cat
39. Effect of risperidone on hostility in schizophrenia
40. The extended amygdala: Are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety?
41. Effects of intracerebroventricular administration of 5-HT receptor agonists on the maternal aggression of rats
42. Control of aggression and agitation in patients with dementia: Efficacy and safety of risperidone
43. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia
44. Social information-processing factors in reactive and proactive aggression in children's peer groups
45. Comparison of the effects of aging on 5-HT7 and 5-HT1A receptors in discrete regions of the circadian timing system in hamsters
46. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin on the cholinergic contraction in guinea pig and human airways in vitro
47. Kainic acid lesions of the cat's antero-medial hypothalamus and emotional-defensive response evoked by carbachol injection to the same loci
48. Effects of hypothalamic stimulation on mesencephalic neurons
49. Further studies on the effects of amygdaloid stimulation and ablation on hypothalamically elicited attack behavior in cats
50. The development of aggressive behavior from the perspective of a developing behaviorism
51. Reversibility by temporal-lobe resection of the behavioral abnormalities of temporal-lobe epilepsy
52. Chemical lesions of both dorsal and median raphe nuclei and changes in social and aggressive behaviour in rats
53. A double-blind pilot study of risperidone in the treatment of conduct disorder
54. The neural pathways mediating quiet-biting attack behavior from the hypothalamus in the cat: A functional autoradiographic study
55. The organization of the hypothalamic pathways mediating affective defense behavior in the cat
56. The role of the anterior hypothalamus in affective defense behavior elicited from the ventromedial hypothalamus of the cat
57. Distribution of substance P-like immunoreactivity in guinea pig central nervous system
58. The amygdala modulates prefrontal cortex activity relative to conditioned fear
59. Shock-induced aggression: Opposite effects of intraventricularly infused dopamine and norepinephrine
60. Paradoxical absence of aggression during naloxone-precipitated morphine withdrawal
61. Clozapine reduces violence and persistent aggression in schizophrenia
62. The participation of serotoninergic system in the regulation of emotional-defensive behavior evoked by intrahypothalamic carbachol injections in the cat
63. Ibotenic acid lesions in the bed nucleus of the stria terminalis attenuate conditioned stress-induced increases in prolactin, ACTH and corticosterone
64. Hypothalamic functions in psychosomatic interrelations
65. Studies on cortico-hypothalamic relations in cat and man
66. Medial amygdaloid suppression of predatory attack behavior in the cat: I. Role of a substance P pathway from the medial amygdala to the medial hypothalamus
67. Medial amygdaloid suppression of predatory attack behavior in the cat: II. Role of a GABAergic pathway from the medial to the lateral hypothalamus
68. Morphine effects on maternal aggression, pup care and analgesia in mice
69. Sterotactic amygdalotomy for convulsive and behavioral disorders
70. Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis
71. Temporal neocortical afferent connections to the amygdala in the Rhesus Monkey
72. The role of stereotactic amygdalotomy in the treatment of temporal lobe epilepsy associated with behavioral disorders
73. Amygdaloid projections to the mesencephalon, pons and medulla oblongata in the cat
74. Unit activities in the hypothalamus and midbrain during stimulation of hypothalamic attack sites
75. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial
76. Opiate involvement in postpartum aggression in rats
77. Preliminary analysis of functions of the temporal lobes in monkeys
78. Cholecystokinin-induced anxiety in rats: Relevance of pre-experimental stress and seasonal variations
79. Coping with stress in rats and mice: Differential peptidergic modulation of the amygdala-lateral septum complex
80. A direct input from the amygdala to the thalamus and the cerebral cortex
81. Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat
82. A potential 5-HT1A receptor antagonist: p-MPPI
83. Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists
84. Distribution of Substance P, somatostatin and neurotensin in the human hypothalamus
85. Projections to the subcortical forebrain from anatomically defined regions of the medial geniculate body in the rat
86. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats
87. The objects attacked by cats during stimulation of the hypothalamus
88. Serotonin-, substance P- or leucineenkephalin-containing neurons in the midbrain periaqueductal gray and nucleus raphe dorsalis send projection fibers to the central amygdaloid nucleus in the rat
89. Serotonin-, substance P- and tyrosine hydroxylase-like immunoreactive neurons projecting from the periaqueductal gray to the ventromedial hypothalamic nucleus in the rat
90. Serotonin-, substance P- and tyrosine hydroxylase-like immunoreactive neurons projecting from the midbrain periaqueductal gray to the nucleus tractus solitarii in the rat
91. Amygdaloid projections to prefrontal and motor cortex
92. Empirical evidence for overt and covert patterns of antisocial conduct problems: A meta- analysis
93. Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation
94. 8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats
95. Role of NMDA receptors in hypothalamic facilitation of feline defensive rage elicited from the midbrain periaqueductal gray
96. Cholecystokinin B receptors in the periaqueductal gray potentiate defensive rage behavior elicited from the medial hypothalamus of the cat
97. Effects of psychotropic drugs upon the hypothalamic rage response in cats
98. Distribution of the substance P receptor (NK-1 receptor) in the central nervous system
99. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
100. The episodic dyscontrol syndrome
101. Behavioral alterations produced by chronic naloxone injections
102. Aggression classification and treatment response
103. Biochemical characterization and anatomical distribution of a major form of unamidated precursor of substance P in rat brain
104. Effects of dominance rank on d-amphetamine-induced increases in aggression
105. Is the hypothalamus a center of emotion?
106. The effect of strychnine sulphate on the emotional mimetic functions of the hypothalamus of the cat
107. Action of metrazol (Pentamethylenetetrazol) on the hypothalamus of the cat
108. Partial antagonism of 8-OH-DPAT'S effects on male rat sexual behavior with a D2, but not a 5-HT1A, antagonist
109. The excitatory action of substance P and stimulation of the stria terminalis bed nucleus on preoptic neurones
110. Cortical afferents to the extended amygdala
111. Ethological and 6-[18F]fluoro-L-DOPA-PET profiles of long-term vulnerability to chronic amphetamine
112. Predatory violence during mass murder
113. Amphetamines: Aggressive and social behavior
114. Epsiodic behavioral disorders and limbic ictus
115. Hypothalamic, other diencephalic, and telencephalic neurons that project to the dorsal midbrain
116. The episodic dyscontrol syndrome in childhood
117. Substance P and excitatory transmitter of primary sensory neurons
118. Neurotransmitter functions of mammalian tachykinins
119. Aggression and epilepsy rage in children with temporal lobe epilepsy
120. Morphological Evidence for a substance P projection from medial septum to hippocampus
121. Properties of ventromedial hypothalamic neurons with axons to midbrain central gray
122. Implications of immediate-early gene induction in the brain following sexual stimulation of female and male rodents
123. Aggression
124. Arginine vasopressin, fever and temperature regulation
125. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells
126. Central gray modulation of affective defense in differentially sensitive to naloxone
127. An autoradiographic study of the projections of the central nucleus of the monkey amygdala
128. 1 receptor. Part II: Distribution and pathophysiological
129. Activation of 5-HT2 receptors facilitates depolarization of neocortical neurons by N-methyl-D-aspartate
130. Multiple mechanisms of serotonin 5-HT2 receptor desensitization
131. Origin of cholinergic fibers in the basolateral nucleus of the amygdaloid complex by using sensitive double-labeling technique of retrograde biotinized tracer and immunocytochemistry
132. The recombinant 5-HT1A receptor: G protein coupling and signalling pathways
133. Hyperphagia, rage, and dementia accompanying a ventromedial hypothalamic neoplasm
134. Understanding and preventing violence
135. Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat
136. Methamphetamine abuse and emergency department utilization
137. The medial amygdala: Serotonergic inhibition of shock-induced aggression and pain sensitivity in rats
138. The influence of injection of 5,6-dihydroxytryptamine to the dorsal raphe nucleus on carbachol-induced defensive behavior and regional brain amine content in the cat
139. Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice
140. Vagus nerve stimulation
141. Afferent projections related to attack sites in the ventral midbrain tegmentum of the cat
142. Differential effects of ethanol on feline rage and predatory attack behavior: An underlying neural mechanism
143. NMDA receptors in the midbrain periaqueductal gray mediate hypothalamically evoked hissing behavior in the cat
144. Aggressiveness in temporal lobe epileptics and its relation to cerebral dysfunction and environmental factors
145. The pathways mediating affective defense and quiet biting attack behavior from the midbrain central gray of the cat: An autoradiographic study
146. Regulation of feline aggression by the bed nucleus of stria terminalis
147. Opioidergic mechanism mediating aggressive behavior in the cat
148. 2/1C receptors in the midbrain periaqueductal gray differentially modulate defensive rage behavior elicited from the medial hypothalamus of the cat
149. Affective defense behavior elicited from the feline midbrain periaqueductal gray is regulated by mu- and delta-opioid receptors
150. An enkephalinergic mechanism involved in amygdaloid suppression of affective defense behavior elicited from the midbrain periaqueductal gray in the eat
151. D-2 dopamine receptor involvement in the regulation of quiet biting attack behavior in the cat
152. Basal amygdaloid facilitation of midbrain periaqueductal gray elicited defensive rage behavior in the cat is mediated through NMDA receptors
153. Opioid peptides within the midbrain periaqueductal gray suppress affective defense behavior in the cat
154. Naloxone-induced modulation of feline aggression elicited from midbrain periaqueductal gray
155. Evidence that substance P is utilized in medial amygdaloid facilitation of defensive rage behavior in the cat
156. Supracapsular bed nucleus of the stria terminalis contains central and medial extended amygdala elements: Evidence from anterograde and retrograde tracing experiments in the rat
157. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA)
158. Neural substrates of aggression and rage in the cat
159. Suppression of attack behavior in the cat by the prefrontal cortex: Role of the mediodorsal thalamic nucleus
160. Effects of electrical stimulation of the medial aspect of the prefrontal cortex upon attack behavior in cats
161. The pathway from the mediodorsal nucleus of thalamus to the hypothalamus in the cat
162. The origin of the afferent supply to the mediodorsal thalamic nucleus: Enhancement of HRP transport by selective lesions
163. Neural substrate of aggression and flight in the cat
164. Neuropharmacology of brain-stimulation-evoked aggression
165. Differential efferent projections of the anterior and posterior cingulate gyrus to the thalamus in the cat
166. Region-specific changes in 5-HT(1A) receptor-activated G-proteins in rat brain following chronic buspirone
167. The effect of a cholecystokinin agonist on masseter muscle activity in the cat
168. Drugs and violence among Ontario students
169. Afferent projections to affective attack sites in cat hypothalamus
170. The effects of codeine on human aggressive responding
171. Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine
172. Septal and amygdalar efferents to the hypothalamus which facilitate hypothalamically elicited intraspecific aggression and associated hissing in the cat. An autoradiographic study
173. Weight loss and shock-elicited aggression as indices of morphine abstinence in rats
174. Organization of some brainstem and limbic connections of the hypothalamus
175. Development of physical dependence on and tolerance to morphine in rats treated with morphine-admixed food
176. Sex differences in function of a pheromonally stimulated pathway: Role of steroids and the main olfactory system
177. The relationship of violent behaviour to focal cerebral disease
178. The role of D1 and D2 receptors in dopamine agonist-induced modulation of affective defense behavior in the cat
179. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate affective defense behavior in the cat
180. Methamphetamine in psychiatric emergencies
181. Child behavioural problems and temporal lobe epilepsy
182. 5-CT stimulation of adenylyl cyclase activity in guinea-pig hippocampus: Evidence for involvement of 5-HT7 and 5-HT1A receptors
183. Heightened aggressive behavior during morphine withdrawal: Effects of d-amphetamine
184. Morphine withdrawal aggression: Modification with D1 and D2 receptor agonists
185. Effects of catecholamines on behavior
186. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
187. Enkephalin-containing pathway: Amygdaloid efferents in the stria terminalis
188. Changes at cholecystokinin receptors induced by long-term treatment with diazepam and haloperidol
189. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro
190. Selective increase of offensive behavior in the rat following intrahypothalamic 5,7-DHT-induced serotonin depletion
191. Subtyping aggression in children and adolescents
192. Subtypes of aggression and their relevance to child psychiatry
193. The effects of clozapine on aggression and substance abuse in schizophrenic patients
194. Pain modulation by release of the endogenous cannabinoid anandamide
195. Substance P-induced inward current in identified auditory efferent neurons in rat brain stem slices
196. Distribution of cells containing mRNA's encoding substance P and neurokinin B in the rat central nervous system
197. Directed attack elicited from hypothalamus
198. "Sham Rage" in Man
199. Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission
200. Neurokinin-1 expression and co-localization with glutamate and GABA in the hypothalamus of the cat
201. The effects of chronic treatment and withdrawal of CNS depressants on aggressive behavior
202. 5-HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons
203. Changes in the aggressive behavior of cats treated with amphetamine